The plaintiffs in the case were the Federal Trade Commission, and seven states, including New York and California. Those same plaintiffs last month obtained a $40 million settlement for the same claims from Vyera Pharmaceuticals, the company that Shkreli had founded. “Americans can rest easy because Martin Shkreli is a pharma bro no more,” said New York Attorney General Letitia James. Shkreli is serving a seven-year federal prison term for financial crimes unrelated to his controversial price increase of Daraprim, a drug used to treat parasitic infections in pregnant women, babies, HIV patients, and others. Shkreli controversially raised the drug’s price from $13.50 per pill to a whopping $750 per pill in 2015.
Read more of this story at Slashdot.